https://doi.org/10.4081/972

The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review

Vol. 50 No. 1 (2006)
Published: 30 June 2009
Abstract Views: 547
PDF: 343
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

F Cappello
support@pagepress.org
A Ribbene
C Campanella
AM Czarnecka
R Anzalone
F Bucchieri
This review addresses the significance of the expression of proliferating cell nuclear antigen (PCNA), p53 and some heat shock proteins (Hsps) in prostate carcinoma (PC). In fact, PCNA and p53 are two widely discussed tools in PC diagnosis, mainly because of the controversy regarding the significance of their expression during prostate cancer development and progression. At the same time, only few studies have shown the potential role of Hsps in carcinogenesis and their overexpression in pre-neoplastic and neoplastic lesions of the prostate.We briefly describe the physiological roles of Hsps in normal cells, and the significance of their immunohistochemical detection in PC as well as in pre-cancerous lesions of the prostate.We will also discuss the possible functional interactions of these molecules in both dysplastic and neoplastic cells.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Cappello, F., Ribbene, A., Campanella, C., Czarnecka, A., Anzalone, R., & Bucchieri, F. (2009). The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review. European Journal of Histochemistry, 50(1), 25–34. https://doi.org/10.4081/972

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.